Featured Story Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting December 9, 2024-Sera Prognostics
Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting December 9, 2024-Sera Prognostics
Conformal Medical Announces Launch of the GLACE Study with Next-Gen CLAAS® AcuFORM™ Left Atrial Appendage Occlusion Device October 2, 2024-Conformal
Venova Medical Announces $30 Million Series B Financing and Appointment of New Board Member September 4, 2024-Venova
PanTher Therapeutics Receives FDA Clearance of IND Application for Phase 1b Study of PTM-101 for the Localized Treatment of Pancreatic Cancer August 13, 2024-PanTher Therapeutics
Sera Prognostics Added to Russell 2000 and 3000 Indexes Following Conclusion of 2024 Indexes Annual Reconstitution July 1, 2024-Sera Prognostics
Epitel Announces Appointment of Wearables Industry Leader Ken Nelson to Board of Directors June 26, 2024-Epitel
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain May 14, 2024-Brixton Biosciences
Epitel Receives FDA 510(k) Clearance for Two New Technologies: REMI Remote EEG Monitoring System for Ambulatory Use and REMI Vigilenz AI For Event Detection April 23, 2024-Epitel
